Supplemental material
Related Research Data
A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1.
Source:
Elsevier BV
Multispecific drugs herald a new era of biopharmaceutical innovation
Source:
Springer Science and Business Media LLC
Bispecific antibodies: a mechanistic review of the pipeline.
Source:
Springer Science and Business Media LLC
Balancing Selectivity and Efficacy of Bispecific Epidermal Growth Factor Receptor (EGFR) × c-MET Antibodies and Antibody-Drug Conjugates.
Source:
Elsevier BV
The making of bispecific antibodies
Source:
Taylor & Francis
Toward Drug-Like Multispecific Antibodies by Design.
Source:
MDPI AG
Bi-specific and tri-specific antibodies- the next big thing in solid tumor therapeutics
Source:
Springer Science and Business Media LLC
FDA approves 100th monoclonal antibody product.
Source:
Springer Science and Business Media LLC
Lung Cancer Cell Lines Harboring MET Gene Amplification Are Dependent on Met for Growth and Survival
Source:
American Association for Cancer Research (AACR)
TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations
Source:
Oxford University Press (OUP)
Linking provided by
